160 related articles for article (PubMed ID: 3017356)
1. Prostaglandins and cannabis--XVI. Antagonism of delta 1-tetrahydrocannabinol action by its metabolites.
Burstein S; Hunter SA; Latham V; Renzulli L
Biochem Pharmacol; 1986 Aug; 35(15):2553-8. PubMed ID: 3017356
[TBL] [Abstract][Full Text] [Related]
2. A major metabolite of delta 1-tetrahydrocannabinol reduces its cataleptic effect in mice.
Burstein S; Hunter SA; Latham V; Renzulli L
Experientia; 1987 Apr; 43(4):402-3. PubMed ID: 3032669
[TBL] [Abstract][Full Text] [Related]
3. Prostaglandins and cannabis--XIII. Cannabinoid-induced elevation of lipoxygenase products in mouse peritoneal macrophages.
Burstein S; Hunter SA; Ozman K; Renzulli L
Biochem Pharmacol; 1984 Aug; 33(16):2653-6. PubMed ID: 6087836
[TBL] [Abstract][Full Text] [Related]
4. Prostaglandins and cannabis XV. Comparison of enantiomeric cannabinoids in stimulating prostaglandin synthesis in fibroblasts.
Burstein S; Hunter SA; Latham V; Mechoulam R; Melchior DL; Renzulli L; Tefft RE
Life Sci; 1986 Nov; 39(19):1813-23. PubMed ID: 3022096
[TBL] [Abstract][Full Text] [Related]
5. Prostaglandins and cannabis--IX. Stimulation of prostaglandin E2 synthesis in human lung fibroblasts by delta 1-tetrahydrocannabinol.
Burstein S; Hunter SA; Sedor C; Shulman S
Biochem Pharmacol; 1982 Jul; 31(14):2361-5. PubMed ID: 6289843
[TBL] [Abstract][Full Text] [Related]
6. Prostaglandins and cannabis. XII. The effect of cannabinoid structure on the synthesis of prostaglandins by human lung fibroblasts.
Burstein S; Hunter SA; Ozman K
Mol Pharmacol; 1983 Jan; 23(1):121-6. PubMed ID: 6865895
[TBL] [Abstract][Full Text] [Related]
7. Δ9-tetrahydrocannabinol and its major metabolite Δ9-tetrahydrocannabinol-11-oic acid as 15-lipoxygenase inhibitors.
Takeda S; Jiang R; Aramaki H; Imoto M; Toda A; Eyanagi R; Amamoto T; Yamamoto I; Watanabe K
J Pharm Sci; 2011 Mar; 100(3):1206-11. PubMed ID: 20891010
[TBL] [Abstract][Full Text] [Related]
8. Stimulation of prostaglandin synthesis in WI-38 human lung fibroblasts following inhibition of phospholipid acylation by p-hydroxymercuribenzoate.
Hunter SA; Burstein S; Sedor C
Biochim Biophys Acta; 1984 Apr; 793(2):202-12. PubMed ID: 6324869
[TBL] [Abstract][Full Text] [Related]
9. In vitro effect of delta 9-tetrahydrocannabinol to stimulate somatostatin release and block that of luteinizing hormone-releasing hormone by suppression of the release of prostaglandin E2.
Rettori V; Aguila MC; Gimeno MF; Franchi AM; McCann SM
Proc Natl Acad Sci U S A; 1990 Dec; 87(24):10063-6. PubMed ID: 1979873
[TBL] [Abstract][Full Text] [Related]
10. Urinary excretion half-life of delta 1-tetrahydrocannabinol-7-oic acid in heavy marijuana users after smoking.
Johansson E; Halldin MM
J Anal Toxicol; 1989; 13(4):218-23. PubMed ID: 2550702
[TBL] [Abstract][Full Text] [Related]
11. Prostaglandins and cannabis XIV. Tolerance to the stimulatory actions of cannabinoids on arachidonate metabolism.
Burstein S; Hunter SA; Renzulli L
J Pharmacol Exp Ther; 1985 Oct; 235(1):87-91. PubMed ID: 2995649
[TBL] [Abstract][Full Text] [Related]
12. Pancreatic islet arachidonic acid turnover and metabolism and insulin release in response to delta-9-tetrahydrocannabinol.
Laychock SG; Hoffman JM; Meisel E; Bilgin S
Biochem Pharmacol; 1986 Jun; 35(12):2003-8. PubMed ID: 3013206
[TBL] [Abstract][Full Text] [Related]
13. Phospholipase participation in cannabinoid-induced release of free arachidonic acid.
Burstein S; Budrow J; Debatis M; Hunter SA; Subramanian A
Biochem Pharmacol; 1994 Sep; 48(6):1253-64. PubMed ID: 7945419
[TBL] [Abstract][Full Text] [Related]
14. delta-9-tetrahydrocannabinol (THC) increases brain prostaglandins in the rat.
Bhattacharya SK
Psychopharmacology (Berl); 1986; 90(4):499-502. PubMed ID: 3027735
[TBL] [Abstract][Full Text] [Related]
15. Cannabinoids and pain responses: a possible role for prostaglandins.
Burstein SH; Hull K; Hunter SA; Latham V
FASEB J; 1988 Nov; 2(14):3022-6. PubMed ID: 2846397
[TBL] [Abstract][Full Text] [Related]
16. 3'-Hydroxy- and (+/-)-3',11-dihydroxy-delta 9-tetrahydrocannabinol: biologically active metabolites of delta 9-tetrahydrocannabinol.
Handrick GR; Duffley RP; Lambert G; Murphy JG; Dalzell HC; Howes JF; Razdan RK; Martin BR; Harris LS; Dewey WL
J Med Chem; 1982 Dec; 25(12):1447-50. PubMed ID: 6296389
[TBL] [Abstract][Full Text] [Related]
17. Anandamide and delta 9-THC dilation of cerebral arterioles is blocked by indomethacin.
Ellis EF; Moore SF; Willoughby KA
Am J Physiol; 1995 Dec; 269(6 Pt 2):H1859-64. PubMed ID: 8594893
[TBL] [Abstract][Full Text] [Related]
18. Further studies on the antinociceptive effects of delta 6-THC-7-oic acid.
Doyle SA; Burstein SH; Dewey WL; Welch SP
Agents Actions; 1990 Aug; 31(1-2):157-63. PubMed ID: 2178317
[TBL] [Abstract][Full Text] [Related]
19. Alteration in the level of endogenous hypothalamic prostaglandins induced by delta 9-tetrahydrocannabinol in the rat.
Coupar IM; Taylor DA
Br J Pharmacol; 1982 May; 76(1):115-9. PubMed ID: 6282371
[TBL] [Abstract][Full Text] [Related]
20. Catalytic activity of cytochrome P450 isozymes purified from rat liver in converting 11-oxo-delta 8-tetrahydrocannabinol to delta 8-tetrahydrocannabinol-11-oic acid.
Watanabe K; Matsunaga T; Narimatsu S; Yamamoto I; Imaoka S; Funae Y; Yoshimura H
Biochem Pharmacol; 1991 Aug; 42(6):1255-9. PubMed ID: 1653566
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
